ArticleJournal of diabetes investigation2026
Linderalactone mitigates diabetic renal injury by inhibiting macrophage inflammation via the Dectin1/Syk/CARD9/IRF5/NF-κB pathway.
Hao Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.